Research ArticleOriginal Research

Sample Closet Medications Are Neither Novel Nor Useful

Kari L. Evans, Steven R. Brown and Gerald W. Smetana
The Journal of the American Board of Family Medicine July 2013, 26 (4) 380-387; DOI: https://doi.org/10.3122/jabfm.2013.04.120330

References

  1. 1.↵
    1. Campbell EG,
    2. Rao SR,
    3. DesRoches CM,
    4. et al
    . Physician professionalism and changes in physician-industry relationships from 2004–2009. Arch Int Med 2010;170:1820–6.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Backer EL,
    2. Lebsack JA,
    3. Van Tonder RJ,
    4. Crabtree BF
    . The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract 2000;49:811–6.
    OpenUrlPubMedWeb of Science
  3. 3.↵
    1. Cutrona SL,
    2. Woolhandler S,
    3. Lasser KE,
    4. Bor DH,
    5. McCormick D,
    6. Himmelstein DU
    . Characteristics of recipients of free prescription drug samples: a nationally representative analysis. Am J Public Health 2008;98:284–9.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Chew LD,
    2. O'Young TS,
    3. Hazlet TK,
    4. Bradley KA,
    5. Maynard C,
    6. Lessler DS
    . A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med 2000;15:478–83.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Westfall JM,
    2. McCabe J,
    3. Nicholas RA
    . Personal use of drug samples by physicians and office staff. JAMA 1997;278:141–3.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Aseeri MA,
    2. Miller DR
    . Patient education and counseling for drug samples dispensed at physicians' offices. J Am Pharm Assoc 2003;46:621–3.
    OpenUrl
  7. 7.↵
    1. Symm B,
    2. Averitt M,
    3. Furjuoh SN,
    4. Preece C
    . Effects of using free sample medications on the prescribing practices of family physicians. J Am Board Fam Med 2006;19:443–9.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Adair RF,
    2. Holmgen LR
    . Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med 2005;118:881–4.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Alexander GC,
    2. Zhang J,
    3. Basu A
    . Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care 2008;46:394–402.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Chimonas S,
    2. Kassirer JP
    . No more free drug samples? PLoS Med 2009;6:e10000074.
    OpenUrl
  11. 11.↵
    1. Smetana GW,
    2. Sillman JS
    . Update in new medications for primary care. J Gen Intern Med 2009;24:111–7.
    OpenUrlPubMed
  12. 12.↵
    1. Anderson GM,
    2. Juurlink D,
    3. Detsky AS
    . Newly approved does not always mean new and improved. JAMA 2008;299:1598–600.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Friedman MA,
    2. Woodcock J,
    3. Lumpkin MM,
    4. Shuren JE,
    5. Hass AE,
    6. Thompson LJ
    . The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA 1999;281:1728–34.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.
    1. Baskin HJ,
    2. Cobin RH,
    3. Duick DS,
    4. et al
    . American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457–69.
    OpenUrlPubMed
  15. 15.
    1. Snow V,
    2. Weiss K,
    3. Wall EM,
    4. Mottur-Pilson C
    ; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headaches. Ann Intern Med 2002;137:840–9.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.
    1. Qaseem A,
    2. Snow V,
    3. Denberg TD,
    4. et al
    . Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2009;151:639–49.
    OpenUrlPubMedWeb of Science
  17. 17.
    1. Hochberg MC,
    2. Altman RD,
    3. April K,
    4. et al
    . American College of Rheumatology 2012 recommendations for the use the nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012;64:465–74.
    OpenUrlPubMedWeb of Science
  18. 18.
    American Diabetes Association. Standards of medical care in diabetes 2012. Diabetes Care 2012;35:S11–63.
    OpenUrlFREE Full Text
  19. 19.
    American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington: APA; 2010.
  20. 20.
    1. Ternent CA,
    2. Bastawrous AL,
    3. Morin NA,
    4. et al
    .; The Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the evaluation and management of constipation. Dis Colon Rectum 2007;50:2013–22.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.
    1. Grundy SM,
    2. Cleeman JI,
    3. Merz CN,
    4. et al
    .; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227–39.
    OpenUrlAbstract/FREE Full Text
  22. 22.
    1. McVary KT,
    2. Roehrborn CG,
    3. Avins BL,
    4. et al
    . Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011;185:1793–803.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.
    1. Carville SF,
    2. Arendt-Nielsen S,
    3. Blotman F,
    4. et al
    . EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67:536–41.
    OpenUrlAbstract/FREE Full Text
  24. 24.
    Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda: GOLD; 2010.
  25. 25.↵
    1. Chobanian AV,
    2. Bakris GL,
    3. Black HR,
    4. et al
    . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–42.
    OpenUrlCrossRefPubMed
  26. 26.↵
    National Institute for Health and Care Excellence. Urinary incontinence: the management of urinary incontinence in women. Available from: http://www.nice.org.uk/cg40. Accessed April 25, 2012.
  27. 27.
    National Institute for Health and Care Excellence. The management of bipolar disorder in adults, children, and adolescents, in primary and secondary care. Available from: www.nice.org.uk/cg038. Accessed April 30, 2012.
  28. 28.↵
    Target Pharmacy. $4 Generic drugs listed by condition. Available from: http://sites.target.com/site/en/spot/page.jsp?title=pharmacy_generic_drugs_condition. Accessed April 25, 2012.
  29. 29.↵
    1. Gagne JJ,
    2. Choudhry NK
    . How many “me-too” drugs is too many? JAMA 2011;305:711–12.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Goldberg NH,
    2. Schneeweiss S,
    3. Kowal MK,
    4. Gagne JJ
    . Availability of comparative efficacy data at the time of drug approval in the United States. JAMA 2011;305:1786–9.
    OpenUrlCrossRefPubMed
  31. 31.↵
    Institute of Medicine. Clinical practice guidelines we can trust. March 23, 2011. Available from: http://www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx. Accessed April 25, 2012.
  32. 32.↵
    1. Dong BJ,
    2. Hauck WW,
    3. Gambertoglio JG,
    4. et al
    . Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA 1997;277:1205–13.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Kale MS,
    2. Bishop TF,
    3. Federman AD,
    4. Keyhani S
    . “Top 5” lists top $5 billion. Arch Intern Med 2011;171:1856–8.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Piette JD,
    2. Heisler M,
    3. Wagner TH
    . Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med 2004;164:1749–55.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Madden JM,
    2. Graves AJ,
    3. Zhang F,
    4. et al
    . Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA 2008;299:1922–8.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Sagall RJ
    . Can your patients afford the medications you prescribe? Fam Pract Manag 2006;13:67–9.
    OpenUrlPubMed
  37. 37.↵
    1. Brown SR
    . Closing the sample closet. Fam Pract Manag 2006;13:16–21.
    OpenUrlPubMed
  38. 38.↵
    1. Erickson SH,
    2. Cullison S
    . Closing the sample closet. Fam Pract Manag 1995;October:43–47.
  39. 39.↵
    1. Brennan TA,
    2. Rothman DJ,
    3. Blank L,
    4. et al
    . Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429–33.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    Puget Sound Health Alliance. Position statement on use of pharmaceutical samples in practice locations. Available from: http://www.pugetsoundhealthalliance.org/services/documents/HealthAlliancePosition_RxSamples_053006.pdf. Accessed April 25, 2012.
  41. 41.↵
    1. Fugh-Berman A,
    2. Brown SR,
    3. Trippett R,
    4. et al
    . Closing the door on pharma? A national survey of family medicine residencies regarding industry interactions. Acad Med 2011;86:649–54.
    OpenUrlPubMed
  42. 42.↵
    1. Hall KB,
    2. Tett SE,
    3. Nissen LM
    . Perceptions of prescription medicine samples on prescribing by family physicians. Med Care 2006;44:383–7.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Cohen ML
    . Taming the sample closet. Fam Pract Manag 2006;13:43–6.
    OpenUrlPubMed
  44. 44.↵
    1. Evans KL,
    2. Brown SR
    . Many sample closet medications are expired. J Am Board Fam Med 2012;25:394–5.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. O'Brien MA,
    2. Rogers S,
    3. Jamtvedt G,
    4. et al
    . Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007;(4):CD000409.
  46. 46.↵
    1. Allen M,
    2. Ferrier S,
    3. O'Connor N,
    4. Fleming I
    . Family physicians' perception of academic detailing: a quantitative and qualitative study. BMC Med Educ 2007;7:36.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Avorn J
    . Teaching clinicians about drugs–50 years later, whose job is it? N Engl J Med 2011;364:1185–7.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Zweifler J,
    2. Hughes S,
    3. Schafer S,
    4. Garcia B,
    5. Grasser A,
    6. Salazar L
    . Are sample medicines hurting the uninsured? J Am Board Fam Pract 2002;15:361–6.
    OpenUrlAbstract
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords